[Prevention of feto-maternal isoimmunization, in particular by means of anti-Rh immunoglobulins].
D000017:ABO Blood-Group System; D000906:Antibodies / Q000032:analysis; D001787:Blood Group Incompatibility; D036861:Delivery, Obstetric; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D005331:Fetomaternal Transfusion; D006801:Humans; D007231:Infant, Newborn; D010956:Plasmapheresis; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins / Q000627:therapeutic use*
D000017:ABO Blood-Group System; D000906:Antibodies; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins
Prévention de l'iso-immunisation foeto-maternelle, particulièrement par l'utilisation des immunoglobulines anti-Rh.